Articles

Terns Articles

October 22, 2020MarketScreenerNews

Terns Pharmaceuticals to Present Clinical Data on Improved TERN-101 Tablet Formulation at the Paris NASH Digital Experience

(marketscreener.com) Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused ... See more »
October 13, 2020MarketScreenerNews

Terns Pharmaceuticals to Present Positive Data on Single-Agent and Combination NASH Programs at The Liver Meeting Digital Experience 2020

(marketscreener.com) FOSTER CITY, Ca. October 14, 2020 -Terns Pharmaceuticals, Inc., a biopharmaceuti... See more »
September 11, 2020PharmaLeadersNews

Terns Pharmaceuticals Receives Fast Track Designation for TERN-201 as a Treatment for NASH

Terns recently completed a Phase 1 clinical study of TERN-201, which demonstrated that single and mul... See more »
August 31, 2020MarketScreenerNews

Terns Pharmaceuticals to Present at Upcoming Investor Conferences

(marketscreener.com) Terns Pharmaceuticals, Inc., a biopharmaceutical company focused on developing b... See more »
August 21, 2020State of AffairsNews

Terns Pharmaceuticals to Present Data on Multiple NASH Programs at The Digital International Liver Congress 2020

-Single doses of TERN-201 were safe and well tolerated and demonstrated potent, selective, and sustai... See more »
July 30, 2020Drug GeniusNews

TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial

Phase 1 repeated dosing of Voriconazole Inhalation Powder of up to 80 mg/dose in healthy subjects for... See more »
July 28, 2020State of AffairsNews

Terns Pharmaceuticals and Hansoh Pharma Announce Collaboration and License Agreement for TRN-000632 in Greater China

-TRN-000632 is a potent allosteric inhibitor of BCR-ABL in development for the treatment of CML- -Ter... See more »
June 19, 2020State of AffairsNews

Terns Pharmaceuticals Initiates the LIFT Study, a Phase 2a Clinical Trial of TERN-101 for the Treatment of NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing... See more »
May 25, 2020MarketScreenerNews

Terns Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference

(marketscreener.com) Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on disco... See more »
April 9, 2020Good Stock InvestNews

2019 annual financial results and update on the activities of the Company

RESOLVE-IT Phase 3 clinical trial interim results expected by the end of May 2020 Cash position at € ... See more »
August 13, 2019VARINDIAPress Release

Terns Pharmaceuticals Announces Positive Interim Results From Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing... See more »
January 18, 2019Business WirePress Release

Terns Pharmaceuticals與上海拓臻生物科技有限公司宣布任命Erin Quirk醫學博士為醫務長

加州聖馬提歐和中國上海--(BUSINESS WIRE)--(美國商業資訊)--Terns Pharmaceuticals Inc. 是一家全球性生物製藥公司(以下簡稱「拓瑧」),致力於治療非酒精性脂肪... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...